Table 2 Plasma lipid levels

Whole cohort (n = 125)

Controls (n = 53)

1.17 ± 0.61

4.71 ± 0.85

2.70 ± 0.78

1.49 ± 0.45

1.97 ± 0.77

MCI (n = 48)

1.12 ± 0.40

4.60 ± 0.87

2.66 ± 0.80

1.46 ± 0.41

1.96 ± 0.83

AD (n = 24)

1.22 ± 0.53

5.36 ± 1.16^*,**

3.09 ± 0.81

1.73 ± 0.66

1.96 ± 0.79

p-value

–^a

0.004^a

–^a

–^a

–^a

B/AAs (n = 58)

Controls (n = 25)

1.24 ± 0.57

4.79 ± 0.91

2.81 ± 0.81

1.41 ± 0.38

2.12 ± 0.83

MCI (n = 24)

1.00 ± 0.27

4.52 ± 0.90

2.66 ± 0.92

1.42 ± 0.42

2.07 ± 1.03

AD (n = 9)

1.13 ± 0.44

5.43 ± 1.36

3.19 ± 0.68

1.74 ± 0.79

1.98 ± 0.58

p-value

–^a

–^a

–^a

–^a

–^a

NHWs (n = 67)

Controls (n = 28)

1.11 ± 0.66

4.64 ± 0.80

2.60 ± 0.74

1.55 ± 0.50

1.83 ± 0.70

MCI (n = 24)

1.23 ± 0.48

4.69 ± 0.86

2.65 ± 0.68

1.50 ± 0.41

1.85 ± 0.58

AD (n = 15)

1.27 ± 0.59

5.31 ± 1.07

3.03 ± 0.90

1.71 ± 0.61

1.95 ± 0.91

p-value

–^a

0.049^a

–^a

–^a

–^b